請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/65374
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳瑞芬 | |
dc.contributor.author | Chien-Liang Lin | en |
dc.contributor.author | 林建良 | zh_TW |
dc.date.accessioned | 2021-06-16T23:39:18Z | - |
dc.date.available | 2013-08-01 | |
dc.date.copyright | 2012-08-01 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-07-25 | |
dc.identifier.citation | Part I:
1.Maret W, Vallee BL. Thiolate ligands in metallothionein confor redox activity on Zn2+ chelators. Proc Natl Acad Sci 1998; 95: 3478–3482. 2.Bozym RA, Thompson RB, Stoddard AK, Fierke CA. Measuring picomolar intracellular exchangeable zinc in PC-12 cells using a ratiometric fluorescence biosensor. ACS Chem Biol 2006;1:103-111. 3.Cheung P-Y, Wang W, Schulz R. Glutathione protects against myocardial ischemia-reperfusion injury by detoxifying peroxynitrite. J Mol Cell Cardiol 2000; 32: 1669–1678. 4.Juhaszova M, Zorov DB, Kim S-H, Pepe S, Fu Q, Fishbein KW et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113: 1535–1549. 5.Yellon DM and Hausenloy DJ. Myocardial Reperfusion Injury. N Engl J Med 2007; 357: 1121-1135. 6.Kang YJ, Li G, Saari JT. Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am J Physiol 1999; 26: H993-H997. 7.Wiseman DA, Wells SM, Wilham J, Hubbard M, Welker JE, Black SM. Endothelial response to stress from exogenous Zn2+ resembles that of NO-mediated nitrosative stress, and is protected by MT-1 overexpression. Am J Physiol 2006; 291: C555–C568. 8.Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004; 41: 351-365. 9.Zhang Y, Wang H, Li J, Dong L, Xu P, Chen W et al. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenease activation in peroxynitrite toxicity to mature rat oligodendrocytes. J Biol Chem. 2006; 281:9460-9470. 10.Jang Y, Wang H, Xi J, Mueller RA, Norfleet EA, Xu Z. NO mobilizes intracellular Zn2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes. Cardiovasc Res 2007; 75: 426–433. 11.Xi J, Tian W, Zhang L, Jin Y, Xu Z. Morphine prevents the mitochondrial permeability transition pore opening through NO/cGMP/PKG/Zn2+/GSK-3b signal pathway in cardiomyocytes. Am J Physiol 2010; 298: H601–H607. 12.Mclntosh R, Lee SY, Ghio AJ, Xi J, Zhu M, Shen X et al. The critical role of intracellular zinc in adenosine A2 receptor activation induced cardioprotection against reperfusion injury. J Mol Cell Cardiol 2010; 49: 41–47. 13.Karagulova G, Yue Y, Moreyra A, Boutjdir M, Korichneva I. Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase c isoforms. JPET 2007; 321: 517–525. 14.Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, Kaczmarek LK et al. Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci 2003; 100: 6157–6162. 15.Cornell NW, Crivaro KE. Stability constant for the zinc-dithiothreitol complex. Analy Biochem 1972; 47: 203-208. 16.Lin T, Mak NK, Yang MS. MAPK regulate p53-dependent cell death induced by benzo[a]pyrene: Involvement of p53 phosphorylation and acetylation. Toxicology 2008; 247: 145–153. 17.Sadik CD, Sies H, Schewe T. Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. Biochem Pharmacol 2003; 65: 773–781. 18.Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res. 2008; 103:983-991.Gross ER, Hsu AK, Gross GJ. Opioid-Induced cardioprotection occurs via glycogen synthase Kinase inhibition during reperfusion in intact rat hearts. Circ Res 2004; 94: 960–966.20.Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK-3b by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008; 117: 2761–2768. 21.Miura T, Miki T. GSK-3β, a therapeutic target for cardiomyocyte protection. Circ J 2009; 73: 1184–1192. 22.Yook JI, Li X-Y, Ota I, Hu C, Kim HS, Kim NH et al. A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 2006; 8: 1398–1406. 23.Beurel E, Jope BS. The paradoxical pro-and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog in Neurobiol 2006; 79: 173–189. 24.Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241. 25.Sheridan C, Brumatti G, Elgendy M, Brunet M, Martin SJ. An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs. Oncogene 2010; 29: 6428-6441. 26.Aikawa T, Shinzawa K, Tanaka N, Tsujimoto Y. Noxa is necessary for hydrogen peroxide-induced caspase-dependent cell death. FEBS Letters 2010; 584:681–688. 27.Frederickson CJ, Burdette SC, Frederickson CJ, Sensi SL, Weiss JH, Yin HZ et al.Method for Yidentifying neuronal cells suffering zinc toxicity by use of a novel fluorescent sensor. J Neurosci Methods 2004; 139: 79–89.28.ang, K-T, Chang, W-L, Yang, P-C, Chien, C-L, Lai, M-S, Su, M-J et al. Activation of the transient receptor potential M2 channel and poly(ADP-ribose) polymerase is involved in oxidative stress-induced cardiomyocyte death. Cell Death Differen 2006; 13: 1815-1826. 29.Chanoit G, Lee SR, Xi J, Zhu M, McIntosh RA, Mueller RA et al. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3b. Am J Physiol 2008; 295: H1227–H1223. 30.Lee SY, Chanoit G, McIntosh R, Zvara DA, Xu Z. Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol 2009; 297: H569–H575. 31.Eom TY, Roth KA, Jope RS. Neural precursor cells are protected from apoptosis induced by trophic factor withdrawal or genotoxic stress by inhibitors of glycogen synthase kinase 3. J Biol Chem. 2007;282:22856–22864. 32.Cagnol S, Chambard J-C. ERK and cell death: mechanisms of ERK-induced cell death–apoptosis, autophagy and senescence. FEBS J 2010; 277: 2–21. 33.Kohda Y, Matsunaga Y, Shiota R, Satoh T, Kishi Y, Kawai Y et al. Raf-1/Mek/ERK1/2 signaling pathway in zinc-induced injury in rat renal cortical slices. J Toxicol Sci 2006; 31: 207-217. 34.Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1. Mol Cell 2006;21: 749–760.35.Ding Q, He X, Hsu J-M, Xia W, Chen C-T, Li L-Y et al. Degradation of Mcl-1 by TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol Cell Biol 2007; 27: 4006–4017. 36.Berghe TV, Vanlangenakker N, Parthoens E, Deckers W, evos M, Festjens N et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death & Differen 2010; 17: 922–930. Part II: 1. Chiu, C. C.; Chen, J. Y.; Lin, K. L.; Huang, C. J.; Lee, J. C.; Chen, B. H.; Chen, W. Y.; Lo, Y. H.; Chen, Y. L.; Tseng, C. H.; Lin, S. R., p38 MAPK and NF-κB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells. Cancer Lett. 2010, 295, (1), 92-99. 2. Li, S.; Bao, P.; Li, Z.; Ouyang, H.; Wu, C.; Qian, G., Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. Oncol. Rep. 2009, 21, 1243-1249. 3. Tabuchi, Y.; Matsuoka, J.; Gunduz, M.; Imada, T.; Ono, R.; Ito, M.; Motoki, T.; Yamatsuji, T.; Shirakawa, Y.; Takaoka, M.; Haisa, M.; Tanaka, N.; Kurebayashi, J.; Jordan, V. C.; Naomoto, Y., Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Int. J. Oncol. 2009, 34, 313-319. 4. Hsu, F. L.; Chen, Y. C.; Cheng, J. T. Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats. Planta Med. 2000, 66, (3), 228–230. 5. Giovannini, L.; Migliori, M.; Filippi, C.; Origlia, N.; Panichi, V.; Falchi, M.; Bertelli, A. A.; Bertelli, A. Inhibitory activity of the white wine compounds, tyrosol and caffeic acid, on lipopolysaccharide-induced tumor necrosis factor-alpha release in human peripheral blood mononuclear cells. Int. J. Tissue. React. 2002, 24, (2), 53–56. 6. Simonetti, P.; Gardana, C.; Pietta, P. Caffeic acid as biomarker of red wine intake. Methods Enzymol. 2001, 335, 122–130. 7. Almeida, A. A.; Farah, A.; Silva, D. A.; Nunan, E. A.; Gloria, M. B. Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria. J. Agric. Food Chem. 2006, 54, (23), 8738–8743. 8. Chung, M. J.; Walker, P. A.; Hogstrand, C. Dietary phenolic antioxidants, caffeic acid and Trolox, protect rainbow trout gill cells from nitric oxide-induced apoptosis. Aquat. Toxicol. 2006, 80, (4), 321–328. 9. Ahn, C. H.; Choi, W. C.; Kong, J. Y. Chemosensitizing activity of caffeic acid in multidrug-resistant MCF-7/Dox human breast carcinoma cells. Anticancer Res. 1997, 17, (3C), 1913–1917. 10. Chang, W. C.; Hsieh, C. H.; Hsiao, M. W.; Lin, W. C.; Hung, Y. C.; Ye, J. C. Caffeic acid induces apoptosis in human cervical cancer cells through the mitochondrial pathway. Taiwan J. Obstet. Gynecol. 2010, 49, (4), 419–424. 11. Onori, P.; DeMorrow, S.; Gaudio, E.; Franchitto, A.; Mancinelli, R.; Venter, J.; Kopriva, S.; Ueno, Y.; Alvaro, D.; Savage, J.; Alpini, G.; Francis, H., Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-κB and induction of apoptosis. Int. J. Cancer 2009, 125, (3), 565–76. 12. Tian, X. F.; Pu, X. P. [Caffeic acid (CA) protects cerebellar granule neurons (CGNs) from apoptosis induced by neurotoxin 1-methyl-4-phenylpyridnium (MPP+)]. Beijing Da Xue Xue Bao 2004, 36, (1), 27–30. 13. Khanduja, K. L.; Avti, P. K.; Kumar, S.; Mittal, N.; Sohi, K. K.; Pathak, C. M. Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim. Biophys. Acta. 2006, 1760, (2), 283–289. 14. Lima, C. F.; Fernandes-Ferreira, M.; Pereira-Wilson, C. Phenolic compounds protect HepG2 cells from oxidative damage: relevance of glutathione levels. Life Sci. 2006, 79, (21), 2056–2068. 15. Kang, K. A.; Lee, K. H.; Zhang, R.; Piao, M.; Chae, S.; Kim, K. N.; Jeon, Y. J.; Park, D. B.; You, H. J.; Kim, J. S.; Hyun, J. W. Caffeic acid protects hydrogen peroxide induced cell damage in WI-38 human lung fibroblast cells. Biol. Pharm. Bull. 2006, 29, (9), 1820–1824. 16. Mirzoeva, O. K.; Calder, P. C. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot. Essent. Fatty Acids 1996, 55, (6), 441–449. 17. Lutz, U.; Lugli, S.; Bitsch, A.; Schlatter, J.; Lutz, W. K. Dose response for the stimulation of cell division by caffeic acid in forestomach and kidney of the male F344 rat. Fundam. Appl. Toxicol. 1997, 39, (2), 1311137. 18. Hagiwara, A.; Hirose, M.; Takahashi, S.; Ogawa, K.; Shirai, T.; Ito, N. Forestomach and kidney carcinogenicity of caffeic acid in F344 rats and C57BL/6N x C3H/HeN F1 mice. Cancer Res. 1991, 51, (20), 565515660. 19. Nardini, M.; Leonardi, F.; Scaccini, C.; Virgili, F. Modulation of ceramide-induced NF-κB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants. Free Radic Biol. Med. 2001, 30, (7), 722–733. 20. Jung, J. E.; Kim, H. S.; Lee, C. S.; Park, D. H.; Kim, Y. N.; Lee, M. J.; Lee, J. W.; Park, J. W.; Kim, M. S.; Ye, S. K.; Chung, M. H. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells. Carcinogenesis 2007, 28, (8), 1780–1787. 21. Cohen, C.; Lohmann, C. M.; Cotsonis, G.; Lawson, D.; Santoianni, R., Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod. Pathol. 2003, 16, 574-583. 22. Zaffaroni, N.; Pennati, M.; Colella, G.; Perego, P.; Supino, R.; Gatti, L.; Pilotti, S.; Zunino, F.; Daidone, M. G. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cellular and Molecular Life Sciences 2002, 59, (8), 1406–1412. 23. Ramnath, V.; Rekha, P. S.; Kuttan, G.; Kuttan, R. Regulation of caspase-3 and Bcl-2 expression in Dalton's lymphoma ascites cells by Abrin. Evid Based Complement Alternat Med. 2009, 6, (2), 233–238. 24. Raviv, Z.; Zilberberg, A.; Cohen, S.; Reischer-Pelech, D.; Horrix, C.; Berger, M. R.; Rosin-Arbesfeld, R.; Flescher, E., Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity. Br. J. Pharmacol. 2011, 164, (5), 1433–44. 25. Ghosh, S.; Karin, M. Missing pieces in the NF-κB puzzle. Cell 2002, 109 Suppl, S81–96. 26. Heckman, C. A.; Mehew, J. W.; Boxer, L. M. NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 2002, 21, (24), 3898–3908. 27. Tang, X.; Liu, D.; Shishodia, S.; Ozburn, N.; Behrens, C.; Lee, J. J.; Hong, W. K.; Aggarwal, B. B.; Wistuba, I. I. Nuclear factor‐κB (NF‐κB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 2006, 107, (11), 2637–2646. 28. Weldon, C. B.; Burow, M. E.; Rolfe, K. W.; Clayton, J. L.; Jaffe, B. M.; Beckman, B. S. NF-κB-mediated chemoresistance in breast cancer cells. Surgery 2001, 130, (2), 143–150. 29. Karin, M.; Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol. 2002, 3, (3), 221–227. 30. Ding, R. K.; Ding, W.; Wang, C. K.; Lu, H.; He, Z. M. The effect of survivin on multidrug resistance by epidermal growth factor receptor 2 via NF-κB activating in breast cancer Cells. Cell Biol. Int. 2008, 32, (3), S28–S28. 31. Zhang, X. H.; Su, L. D.; Lu, Q. H.; Liang, Y.; Zhao, X. Y. Relationship between drug resistance and the expression of NF-κB induced in leukemic cells. Zhejiang Da Xue Xue Bao Yi Xue Ban 2004, 33, (5), 421–426. 32. Salvatore, C.; Camarda, G.; Maggi, C. A.; Goso, C.; Manzini, S.; Binaschi, M. NF-κB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780. Int. J. Oncol. 2005, 27, (3), 799–806. 33. Chiu, C. C.; Liu, P. L.; Huang, K. J.; Wang, H. M.; Chang, K. F.; Chou, C. K.; Chang, F. R.; Chong, I. W.; Fang, K.; Chen, J. S.; Chang, H. W.; Wu, Y. C., Goniothalamin inhibits growth of human lung cancer cells through DNA damage, apoptosis, and reduced migration ability. J. Agric. Food Chem. 2011, 59, (8), 4288-4293. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/65374 | - |
dc.description.abstract | Part I:
氧化壓力 (oxidative stress) 和硝化壓力 (nitrosative stress) 都被認為參與了心肌缺血再灌流 (I/R) 所造成的傷害。本研究乃探討是否再灌流時引起之細胞內鋅離子的釋放所造成GSK-3B活化而導致心臟之傷害,而若螯合鋅離子的釋放則能保護心肌細胞。使用時間推移共軛焦顯微鏡 (time-lapse confocal microscopy) 與高親和力超氧化物 (O2-•) 和鋅離子 (Zn2+) 探針對心肌細胞作研究,我們這個研究是首先證明,缺血再灌流 (I/R)、活性氧 (reactive oxygen species) 與活性氮 (reactive oxygen species) 皆會造成顯著地細胞內O2-•增加,進而導致在細胞質和線粒體的Zn2+釋放出來。將心肌細胞置身於一種細胞穿透力強且高親和力之細胞內Zn2+螯合劑,TPEN,可以大大地中和掉Zn2+釋放後所造成的影響 (至少持續24小時),進而明顯地保護細胞,免於受到缺血再灌流、活性氧、活性氮,或鋅離子/鉀離子所誘導之心肌細胞凋亡。在成鼠的心臟實驗,TPEN及baicalein (一種強效的flavonoid) 可明顯保護I/R所造成的傷害。黃酮 (Flavonoids) 和U0126 (一種MEK1/2的抑製劑)在很大程度上抑制心肌細胞凋亡和TPEN敏感性之缺血再灌流或補充細胞內的鋅離子量會持續的誘導細胞外信號調節激酶1和2(ERK1/2) 磷酸化、肝醣合成酶激酶GSK-3B上的P-Ser9去磷酸化和P-Tyr216、GSK-3B和p53在細胞核積累及易位。沉默GSK-3B或p53基因表現是有心臟保護的效果的,顯示出ERK-GSK-3B-P53信號路徑的活化參與鋅離子敏感性的細胞死亡。此外,ERK依賴性的NOXA-髓細胞白血病-1 (MCL-1) 的途徑也參與其中,當沉默NOXA基因表現,會有心臟的保護,而U0126會明顯減少NOXA的表現和MCL-1降解。這樣的結果指出,細胞內鋅離子所造成GSK-3B的活化與心臟之I/R injury有關。TPEN總是相較於其他抑制劑對心臟的保護有更好的效果。因此,在再灌注開始時之急性上游鋅離子螯合劑的使用及天然產品的使用,如: 類黃酮,可能有益於心臟缺血再灌流損傷的治療。 Part II: 咖啡酸(CA)是一種天然酚類化合物,且大量存在藥用植物中。CA的具有多種生物效應,如抗細菌和抗腫瘤的生長。也有報導指出,在小鼠模式中,CA會引起前胃和腎腫瘤。在這裡,我們用兩種人類肺癌細胞株A549和H1299,釐清CA在癌細胞增殖中所扮演的角色。利用生長實驗顯示,CA可適度地促進肺癌細胞的增殖。此外,在處理抗癌藥物紫杉醇(PTX)前,先給予CA,可抑制PTX對癌細胞的毒殺效果。西方墨點法分析表明,CA可促進NF-kB的下游標的-促生存蛋白Survivin和Bcl-2的表現。這和CA誘導的NF-kBp65的核易位的觀察是一致的。我們的研究表明,CA是通過NF-kB信號路徑,而對於PTX治療的肺癌細胞有促細胞增值的作用。這可以提供癌症在化療阻抗性的有進一步的了解。 | zh_TW |
dc.description.abstract | Part I:
Oxidative stress and nitrosative stress are both suggested to be involved in cardiac ischemia-reperfusion (I/R) injury. This study investigate whether reperfusion-induced intracellular Zn2+ (Zn2+i) release activates GSK-3B, resulting in cardiac I/R-injury, and whether acute chelation of the Zn2+i release salvages the live myocardium. Using time-lapse confocal microscopy of cardiomyocytes and high affinity O2-• and Zn2+ probes, the present study is the first to show that I/R, ROS, and RNS all cause a marked increase in the [O2-•]i, resulting in cytosolic and mitochondrial Zn2+ release. Exposure to a cell-penetrating, high affinity Zn2+i chelator, TPEN, largely abolished the Zn2+i release and markedly protected myocytes from I/R-, ROS-, RNS-, or Zn2+/K+ (Zn2+i supplementation)-induced myocyte apoptosis for at least 24 hr after TPEN removal. In adult rat hearts, TPEN or baicalein (a potent flavonoid) again markedly inhibited cardiac I/R injury. Flavonoids and U0126 (a MEK1/2 inhibitor) largely inhibited the myocyte apoptosis and the TPEN-sensitive I/R- or Zn2+i supplement-induced persistent ERK1/2 phosphorylation, dephosphorylation of p-Ser9 on GSK-3B, and the translocation into and accumulation of p-Tyr216 GSK-3B and p53 in, the nucleus. Silencing of GSK-3B or p53 expression was cardioprotective, indicating that activation of the ERK-GSK-3B-p53 signaling pathway is involved in Zn2+i-sensitive myocyte death. Moreover, the ERK-dependent Noxa-Mcl-1 pathway is also involved, since silencing of Noxa expression was cardioprotective and U0126 abolished both the increase in Noxa expression and Mcl-1 degradation. Our results demonstrated that Zn2+i -sensitive activation of GSK-3B is involved in cardiac I/R injury. TPEN always provided more cardioprotection than the other tested inhibitors. Thus, acute upstream Zn2+i chelation at the start of reperfusion and the use of natural products, i.e. flavonoids, may be beneficial in the treatment of cardiac I/R injury. Part II: Caffeic acid (CA), a natural phenolic compound, is abundant in medicinal plants. CA possesses multiple biological effects such as anti-bacterial and anti-cancer growth. CA was also reported to induce fore stomach and kidney tumors in mouse model. Here we used two human lung cancer cell lines, A549 and H1299, to clarify the role of CA in cancer cell proliferation. The growth assay showed that CA promoted the proliferation of the lung cancer cells moderately. Furthermore, pre-treatment of CA rescues the proliferation inhibition induced by sub-IC50 dose of paclitaxel (PTX), an anticancer drug. Western blot showed that CA up-regulated the pro-survival proteins survivin and Bcl-2, the down-stream targets of NF-kB. This is consistent with the observation that CA induced nuclear translocation of NF-kB p65. Our study suggested that the pro-survival effect of CA on PTX-treated lung cancer cells was mediated through NF-kB signaling pathway. This may provide mechanistic insights into chemoresistance of cancer cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T23:39:18Z (GMT). No. of bitstreams: 1 ntu-101-D97b41010-1.pdf: 12551808 bytes, checksum: 0845857b6b2c2d4568db543b8b7669cf (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 口試委員會審定書------------------------------------------------------------------------------- 壹
誌謝------------------------------------------------------------------------------------------- 貳 Part I 中文摘要----------------------------------------------------------------------------------------1 Abstract----------------------------------------------------------------------------------------3 Abbreviations-----------------------------------------------------------------------------------5 Chapter 1 Introduction--------------------------------------------------------------------------6 Chapter 2 Materials and Methods----------------------------------------------------------------12 2.1 Solutions and Chemicals------------------------------------------------------------------13 2.2 Protocols for simulating I/R in neonatal cardiomyocytes or I/R in adult rat hearts------------------------------------------------------------------------------------14 2.3 Time-lapse confocal microscopy in live cardiomyocytes------------------------------------15 2.4 Western blot analysis--------------------------------------------------------------------17 2.5 Transfection with small interfering RNA (siRNA) and quantitative real-time PCR (qPCR)--------------------------------------------------------------------------------17 2.6 In situ detection of myocyte apoptosis---------------------------------------------------19 2.7 Statistics-------------------------------------------------------------------------------19 Chapter 3 Results------------------------------------------------------------------------------20 3.1 Oxidative stress or nitrosative stress induces Zn2+ release from intracellular Zn2+ pools in ventricular myocytes--------------------------------------------------------21 3.2 Positive feedback between the [O2-•]i and [Zn2+]i increases--------------------------22 3.3 The ROS- or RNS-stimulated Zn2+i release induces TPEN-, flavonoid-, and ERK-GSK-3B-sensitive myocyte apoptosis---------------------------------------23 3.4 Simulated ischemia-reperfusion (I/R) also induces Zn2+i release, resulting in TPEN-, ERK-, GSK-3B-, and flavonoid-sensitive myocyte apoptosis----------------------------------------------------------26 3.5 The Zn2+i release may also be involved in I/R injury in adult rat hearts----------------28 3.6 The ERK-dependent GSK-3B-p53 pathway and Noxa-Mcl-1 signaling are both involved in the Zn2+i increase-induced myocyte death----------------------28 Chapter 4 Discussion---------------------------------------------------------------------------33 Acknowledgements-------------------------------------------------------------------------------43 Chapter 5 References---------------------------------------------------------------------------44 Part II Title------------------------------------------------------------------------------------------51 中文摘要---------------------------------------------------------------------------------------52 Abstract---------------------------------------------------------------------------------------53 Chapter 1 Introduction-------------------------------------------------------------------------54 Chapter 2 Materials and Methods----------------------------------------------------------------58 2.1. Cell Cultures---------------------------------------------------------------------------59 2.2. Reagents and Antibodies-----------------------------------------------------------------59 2.3. Growth Proliferation Test---------------------------------------------------------------59 2.4. Western Blot Analysis-------------------------------------------------------------------59 2.5. Preparation of Cytosolic and Nuclear Extracts-------------------------------------------60 2.6. Statistical Analysis--------------------------------------------------------------------60 Chapter 3 Results & Discussion-----------------------------------------------------------------61 3.1. Effect of CA on Proliferation of Lung Cancer Cells--------------------------------------62 3.2. CA Rescues the PTX-Induced Anti-Proliferation in NSCLC Cells------------------------62 3.3. CA Reduces the Activation of Pro-apoptotic in NSCLC Cells------------------------------62 3.4. CA Up-Regulates the Protein Levels of Bcl-2 and Survivin---------------------------63 3.5. CA Induces Up-Regulation and Activation of NF-κB---------------------------------------64 Conclusions----------------------------------------------------------------------------------65 Acknowledgements-------------------------------------------------------------------------------43 Chapter 4 References---------------------------------------------------------------------------67 Part I Figures Figure 1--------------------------------------------------------------------------------------- I Figure 2---------------------------------------------------------------------------------------IV Figure 3---------------------------------------------------------------------------------- -- VII Figure 4-------------------------------------------------------------------------------------- IX Figure 5---------------------------------------------------------------------------------------XII Figure 6---------------------------------------------------------------------------------------XIV Figure 7----------------------------------------------------------------------------------------XVI Figure 8--------------------------------------------------------------------------------------XVIII Figure S1---------------------------------------------------------------------------------------XXI Figure S2-------------------------------------------------------------------------------------XXIII Figure S3-------------------------------------------------------------------------------------- XXV Figure S4------------------------------------------------------------------------------------ XXVII Figure S5------------------------------------------------------------------------------------- XXIX Part II Figures Figure 1---------------------------------------------------------------------------------------XXXI Figure 2--------------------------------------------------------------------------------------XXXII Figure 3-------------------------------------------------------------------------------------XXXIII Figure 4--------------------------------------------------------------------------------------XXXIV Figure 5---------------------------------------------------------------------------------------XXXV Figure 6--------------------------------------------------------------------------------------XXXVI | |
dc.language.iso | zh-TW | |
dc.title | 缺血-再灌流引起之心肌細胞內鋅離子釋放導致細胞凋亡機制之研究 | zh_TW |
dc.title | Intracellular zinc release contributes to ischemia reperfusion-induced myocyte apoptosis | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 方光明,黃娟娟,蔡孟利,楊昆達,潘建源 | |
dc.subject.keyword | 細胞凋亡,缺血再灌流傷害,粒線體,鋅離子,心肌細胞, | zh_TW |
dc.subject.keyword | apoptosis,I/R injury,mitochondria,Zn2+,cardiomyocyte, | en |
dc.relation.page | 111 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-07-25 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 動物學研究所 | zh_TW |
顯示於系所單位: | 動物學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 12.26 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。